• Disease areas
  • Science & technology
  • Partnering
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Patients
  • Investors
  • Healthcare professionals
  • News & media
  • Contact us

Investors

Investor highlights Financial results, events and calendar Annual Report 2023 ESG Share information Investor Portal Bond information Company announcements and press releases Annual General Meeting 2024 Contact Investor Relations

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

Patient help Supplier help Product list Contact us Annual Report ESG reporting Novo Nordisk Foundation

Follow us

Social media community guidelines LinkedIn YouTube Facebook X (Twitter) Instagram TikTok

Find your local office

Select location
© 2024 Novo Nordisk A/S
Data Privacy
Cookie policy
Cookie settings

change